BIOQ
Price
$43.19
Change
-$0.25 (-0.58%)
Updated
Jul 10 closing price
Capitalization
5.24M
XGN
Price
$7.26
Change
+$0.04 (+0.55%)
Updated
Jul 25 closing price
Capitalization
27.06M
2 days until earnings call
Interact to see
Advertisement

BIOQ vs XGN

Header iconBIOQ vs XGN Comparison
Open Charts BIOQ vs XGNBanner chart's image
BIOQUAL
Price$43.19
Change-$0.25 (-0.58%)
Volume$100
Capitalization5.24M
Exagen
Price$7.26
Change+$0.04 (+0.55%)
Volume$95.65K
Capitalization27.06M
BIOQ vs XGN Comparison Chart in %
Loading...
BIOQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOQ vs. XGN commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOQ is a StrongBuy and XGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (BIOQ: $43.19 vs. XGN: $7.26)
Brand notoriety: BIOQ and XGN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIOQ: 26% vs. XGN: 39%
Market capitalization -- BIOQ: $5.24M vs. XGN: $27.06M
BIOQ [@Medical Specialties] is valued at $5.24M. XGN’s [@Medical Specialties] market capitalization is $27.06M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOQ’s FA Score shows that 2 FA rating(s) are green whileXGN’s FA Score has 0 green FA rating(s).

  • BIOQ’s FA Score: 2 green, 3 red.
  • XGN’s FA Score: 0 green, 5 red.
According to our system of comparison, BIOQ is a better buy in the long-term than XGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOQ’s TA Score shows that 1 TA indicator(s) are bullish while XGN’s TA Score has 3 bullish TA indicator(s).

  • BIOQ’s TA Score: 1 bullish, 2 bearish.
  • XGN’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BIOQ is a better buy in the short-term than XGN.

Price Growth

BIOQ (@Medical Specialties) experienced а 0.00% price change this week, while XGN (@Medical Specialties) price change was +3.71% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.01%. For the same industry, the average monthly price growth was +4.92%, and the average quarterly price growth was -2.24%.

Reported Earning Dates

BIOQ is expected to report earnings on Apr 11, 2025.

XGN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Medical Specialties (+3.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XGN($27.1M) has a higher market cap than BIOQ($5.24M). XGN YTD gains are higher at: 77.073 vs. BIOQ (-34.660). BIOQ has higher annual earnings (EBITDA): 6.08M vs. XGN (-19.15M). XGN has more cash in the bank: 36.5M vs. BIOQ (3.76M). XGN has higher revenues than BIOQ: XGN (52.5M) vs BIOQ (35.9M).
BIOQXGNBIOQ / XGN
Capitalization5.24M27.1M19%
EBITDA6.08M-19.15M-32%
Gain YTD-34.66077.073-45%
P/E RatioN/AN/A-
Revenue35.9M52.5M68%
Total Cash3.76M36.5M10%
Total DebtN/A23.7M-
FUNDAMENTALS RATINGS
BIOQ vs XGN: Fundamental Ratings
BIOQ
XGN
OUTLOOK RATING
1..100
2081
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
598
PRICE GROWTH RATING
1..100
8736
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOQ's Valuation (12) in the null industry is somewhat better than the same rating for XGN (57). This means that BIOQ’s stock grew somewhat faster than XGN’s over the last 12 months.

BIOQ's Profit vs Risk Rating (100) in the null industry is in the same range as XGN (100). This means that BIOQ’s stock grew similarly to XGN’s over the last 12 months.

BIOQ's SMR Rating (5) in the null industry is significantly better than the same rating for XGN (98). This means that BIOQ’s stock grew significantly faster than XGN’s over the last 12 months.

XGN's Price Growth Rating (36) in the null industry is somewhat better than the same rating for BIOQ (87). This means that XGN’s stock grew somewhat faster than BIOQ’s over the last 12 months.

BIOQ's P/E Growth Rating (76) in the null industry is in the same range as XGN (100). This means that BIOQ’s stock grew similarly to XGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOQXGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
36%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 17 days ago
46%
Bearish Trend 5 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
21%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BIOQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRNS84.150.72
+0.86%
Transcat
YMAB4.77-0.07
-1.45%
Y-mAbs Therapeutics
KRYS147.61-2.39
-1.59%
Krystal Biotech
CCI111.48-2.43
-2.13%
Crown Castle
SONN3.99-0.23
-5.45%
Sonnet BioTherapeutics Holdings Inc

BIOQ and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIOQ has been loosely correlated with SAFLY. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BIOQ jumps, then SAFLY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOQ
1D Price
Change %
BIOQ100%
N/A
SAFLY - BIOQ
34%
Loosely correlated
N/A
PFGTF - BIOQ
24%
Poorly correlated
-64.85%
XGN - BIOQ
23%
Poorly correlated
+0.55%
CNVVF - BIOQ
22%
Poorly correlated
N/A
CHEOY - BIOQ
11%
Poorly correlated
N/A
More

XGN and

Correlation & Price change

A.I.dvisor tells us that XGN and MXCT have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XGN and MXCT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XGN
1D Price
Change %
XGN100%
+0.55%
MXCT - XGN
28%
Poorly correlated
-0.88%
BLFS - XGN
27%
Poorly correlated
+1.44%
RDNT - XGN
27%
Poorly correlated
+2.54%
QDEL - XGN
26%
Poorly correlated
N/A
NTRA - XGN
25%
Poorly correlated
-1.53%
More